94
Views
6
CrossRef citations to date
0
Altmetric
Theme: Arrhythmias & Cardiac Pacing - Review

Pacing in sinus node disease to prevent atrial fibrillation

&
Pages 851-858 | Published online: 10 Jan 2014

References

  • Nielsen JC, Thomsen PE, Højberg S et al.; DANPACE Investigators. A comparison of single-lead atrial pacing with dual-chamber pacing in sick sinus syndrome. Eur. Heart J. 32(6), 686–696 (2011).
  • Lamas GA, Lee KL, Sweeney MO et al.; Mode Selection Trial in Sinus-Node Dysfunction. Ventricular pacing or dual-chamber pacing for sinus-node dysfunction. N. Engl. J. Med. 346(24), 1854–1862 (2002).
  • Andersen HR, Nielsen JC, Thomsen PE et al. Long-term follow-up of patients from a randomised trial of atrial versus ventricular pacing for sick-sinus syndrome. Lancet 350(9086), 1210–1216 (1997).
  • Connolly SJ, Kerr CR, Gent M et al. Effects of physiologic pacing versus ventricular pacing on the risk of stroke and death due to cardiovascular causes. Canadian Trial of Physiologic Pacing Investigators. N. Engl. J. Med. 342(19), 1385–1391 (2000).
  • Sweeney MO, Bank AJ, Nsah E et al.; Search AV Extension and Managed Ventricular Pacing for Promoting Atrioventricular Conduction (SAVE PACe) Trial. Minimizing ventricular pacing to reduce atrial fibrillation in sinus-node disease. N. Engl. J. Med. 357(10), 1000–1008 (2007).
  • Go AS, Hylek EM, Phillips KA et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA 285(18), 2370–2375 (2001).
  • Toff WD, Camm AJ, Skehan JD; United Kingdom Pacing and Cardiovascular Events Trial Investigators. Single-chamber versus dual-chamber pacing for high-grade atrioventricular block. N. Engl. J. Med. 353(2), 145–155 (2005).
  • Healey JS, Connolly SJ, Gold MR et al.; ASSERT Investigators. Subclinical atrial fibrillation and the risk of stroke. N. Engl. J. Med. 366(2), 120–129 (2012).
  • Andersen HR, Thuesen L, Bagger JP, Vesterlund T, Thomsen PE. Prospective randomised trial of atrial versus ventricular pacing in sick-sinus syndrome. Lancet 344(8936), 1523–1528 (1994).
  • Lamas GA, Orav EJ, Stambler BS et al. Quality of life and clinical outcomes in elderly patients treated with ventricular pacing as compared with dual-chamber pacing. Pacemaker Selection in the Elderly Investigators. N. Engl. J. Med. 338(16), 1097–1104 (1998).
  • Lamas GA, Knight JD, Sweeney MO et al. Impact of rate-modulated pacing on quality of life and exercise capacity–evidence from the Advanced Elements of Pacing Randomized Controlled Trial (ADEPT). Heart Rhythm 4(9), 1125–1132 (2007).
  • Haïssaguerre M, Jaïs P, Shah DC et al. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N. Engl. J. Med. 339(10), 659–666 (1998).
  • Iwasaki YK, Nishida K, Kato T, Nattel S. Atrial fibrillation pathophysiology: implications for management. Circulation 124(20), 2264–2274 (2011).
  • Sanagala T, Johnston SL, Groot GD, Santucci P, Rhine DK, Varma N. Left atrial mechanical responses to right ventricular pacing in heart failure patients: implications for atrial fibrillation. J. Cardiovasc. Electrophysiol. 22(8), 866–874 (2011).
  • Vardas PE, Auricchio A, Blanc JJ et al.; European Society of Cardiology; European Heart Rhythm Association. Guidelines for cardiac pacing and cardiac resynchronization therapy: The Task Force for Cardiac Pacing and Cardiac Resynchronization Therapy of the European Society of Cardiology. Developed in collaboration with the European Heart Rhythm Association. Eur. Heart J. 28(18), 2256–2295 (2007).
  • Epstein AE, Dimarco JP, Ellenbogen KA et al.; American College of Cardiology; American Heart Association Task Force on Practice Guidelines; American Association for Thoracic Surgery; Society of Thoracic Surgeons. ACC/AHA/HRS 2008 Guidelines for device-based therapy of cardiac rhythm abnormalities. Heart Rhythm 5(6), e1–e62 (2008).
  • Papageorgiou P, Monahan K, Boyle NG et al. Site-dependent intra-atrial conduction delay. Relationship to initiation of atrial fibrillation. Circulation 94(3), 384–389 (1996).
  • Schuchert A, Rebeski HP, Peiffer T et al.; 3:4 Study Group. Effects of continuous and triggered atrial overdrive pacing on paroxysmal atrial fibrillation in pacemaker patients. Pacing Clin. Electrophysiol. 31(8), 929–934 (2008).
  • Papageorgiou P, Monahan K, Anselme F, Kirchhof C, Josephson ME. Electrophysiology of atrial fibrillation and its prevention by coronary sinus pacing. Semin. Interv. Cardiol. 2(4), 227–232 (1997).
  • Wang M, Siu CW, Lee KL et al. Effects of right low atrial septal vs. right atrial appendage pacing on atrial mechanical function and dyssynchrony in patients with sinus node dysfunction and paroxysmal atrial fibrillation. Europace 13(9), 1268–1274 (2011).
  • Prinzen FW, Hunter WC, Wyman BT, McVeigh ER. Mapping of regional myocardial strain and work during ventricular pacing: experimental study using magnetic resonance imaging tagging. J. Am. Coll. Cardiol. 33(6), 1735–1742 (1999).
  • Barold SS. Repetitive reentrant and non-reentrant ventriculoatrial synchrony in dual chamber pacing. Clin. Cardiol. 14(9), 754–763 (1991).
  • Nielsen JC, Pedersen AK, Mortensen PT, Andersen HR. Programming a fixed long atrioventricular delay is not effective in preventing ventricular pacing in patients with sick sinus syndrome. Europace 1(2), 113–120 (1999).
  • Blanc JJ, De Roy L, Mansourati J et al.; PIPAF Investigators. Atrial pacing for prevention of atrial fibrillation: assessment of simultaneously implemented algorithms. Europace 6(5), 371–379 (2004).
  • Carlson MD, Ip J, Messenger J et al.; Atrial Dynamic Overdrive Pacing Trial (ADOPT) Investigators. A new pacemaker algorithm for the treatment of atrial fibrillation: results of the Atrial Dynamic Overdrive Pacing Trial (ADOPT). J. Am. Coll. Cardiol. 42(4), 627–633 (2003).
  • Ricci R, Santini M, Puglisi A et al. Impact of consistent atrial pacing algorithm on premature atrial complexe number and paroxysmal atrial fibrillation recurrences in brady-tachy syndrome: a randomized prospective cross over study. J. Interv. Card. Electrophysiol. 5(1), 33–44 (2001).
  • Gold MR, Adler S, Fauchier L et al.; SAFARI Investigators. Impact of atrial prevention pacing on atrial fibrillation burden: primary results of the Study of Atrial Fibrillation Reduction (SAFARI) trial. Heart Rhythm 6(3), 295–301 (2009).
  • Sulke N, Silberbauer J, Boodhoo L et al. The use of atrial overdrive and ventricular rate stabilization pacing algorithms for the prevention and treatment of paroxysmal atrial fibrillation: the Pacemaker Atrial Fibrillation Suppression (PAFS) study. Europace 9(9), 790–797 (2007).
  • Mitchell AR, Spurrell PA, Cheatle L, Sulke N. Effect of atrial antitachycardia pacing treatments in patients with an atrial defibrillator: randomised study comparing subthreshold and nominal pacing outputs. Heart 87(5), 433–437 (2002).
  • Lee MA, Weachter R, Pollak S et al.; ATTEST Investigators. The effect of atrial pacing therapies on atrial tachyarrhythmia burden and frequency: results of a randomized trial in patients with bradycardia and atrial tachyarrhythmias. J. Am. Coll. Cardiol. 41(11), 1926–1932 (2003).
  • Bailin SJ, Adler S, Giudici M. Prevention of chronic atrial fibrillation by pacing in the region of Bachmann’s bundle: results of a multicenter randomized trial. J. Cardiovasc. Electrophysiol. 12(8), 912–917 (2001).
  • Padeletti L, Pieragnoli P, Ciapetti C et al. Randomized crossover comparison of right atrial appendage pacing versus interatrial septum pacing for prevention of paroxysmal atrial fibrillation in patients with sinus bradycardia. Am. Heart J. 142(6), 1047–1055 (2001).
  • Padeletti L, Pürerfellner H, Adler SW et al.; Worldwide ASPECT Investigators. Combined efficacy of atrial septal lead placement and atrial pacing algorithms for prevention of paroxysmal atrial tachyarrhythmia. J. Cardiovasc. Electrophysiol. 14(11), 1189–1195 (2003).
  • Hermida JS, Kubala M, Lescure FX et al. Atrial septal pacing to prevent atrial fibrillation in patients with sinus node dysfunction: results of a randomized controlled study. Am. Heart J. 148(2), 312–317 (2004).
  • Verlato R, Botto GL, Massa R et al. Efficacy of low interatrial septum and right atrial appendage pacing for prevention of permanent atrial fibrillation in patients with sinus node disease: results from the electrophysiology-guided pacing site selection (EPASS) study. Circ. Arrhythm. Electrophysiol. 4(6), 844–850 (2011).
  • Mattioli AV, Vivoli D, Mattioli G. Influence of pacing modalities on the incidence of atrial fibrillation in patients without prior atrial fibrillation. A prospective study. Eur. Heart J. 19(2), 282–286 (1998).
  • Healey JS, Toff WD, Lamas GA et al. Cardiovascular outcomes with atrial-based pacing compared with ventricular pacing: meta-analysis of randomized trials, using individual patient data. Circulation 114(1), 11–17 (2006).
  • Sweeney MO, Hellkamp AS, Ellenbogen KA et al.; MOde Selection Trial Investigators. Adverse effect of ventricular pacing on heart failure and atrial fibrillation among patients with normal baseline QRS duration in a clinical trial of pacemaker therapy for sinus node dysfunction. Circulation 107(23), 2932–2937 (2003).
  • Elkayam LU, Koehler JL, Sheldon TJ, Glotzer TV, Rosenthal LS, Lamas GA. The influence of atrial and ventricular pacing on the incidence of atrial fibrillation: a meta-analysis. Pacing Clin. Electrophysiol. 34(12), 1593–1599 (2011).
  • Nielsen JC, Kristensen L, Andersen HR, Mortensen PT, Pedersen OL, Pedersen AK. A randomized comparison of atrial and dual-chamber pacing in 177 consecutive patients with sick sinus syndrome: echocardiographic and clinical outcome. J. Am. Coll. Cardiol. 42(4), 614–623 (2003).
  • Padeletti L, Pontecorboli G, Michelucci A, Mond HG. AAIR or DDDR pacing for sick sinus syndrome: the physiologic conundrum. Europace 14(6), 781–782 (2012).
  • Albertsen AE, Nielsen JC, Poulsen SH et al. Biventricular pacing preserves left ventricular performance in patients with high-grade atrio-ventricular block: a randomized comparison with DDD® pacing in 50 consecutive patients. Europace 10(3), 314–320 (2008).
  • Chan JY, Fang F, Zhang Q et al. Biventricular pacing is superior to right ventricular pacing in bradycardia patients with preserved systolic function: 2-year results of the PACE trial. Eur. Heart J. 32(20), 2533–2540 (2011).
  • Funck RC, Blanc JJ, Mueller HH, Schade-Brittinger C, Bailleul C, Maisch B; BioPace Study Group. Biventricular stimulation to prevent cardiac desynchronization: rationale, design, and endpoints of the ‘Biventricular Pacing for Atrioventricular Block to Prevent Cardiac Desynchronization (BioPace)’ study. Europace 8(8), 629–635 (2006).
  • Cheng S, Keyes MJ, Larson MG et al. Long-term outcomes in individuals with prolonged PR interval or first-degree atrioventricular block. JAMA 301(24), 2571–2577 (2009).
  • Nielsen JC, Thomsen PE, Højberg S et al.; on behalf of the DANPACE investigators. Atrial fibrillation in patients with sick sinus syndrome: the association with PQ-interval and percentage of ventricular pacing. Europace 14(5), 682–689 (2012).
  • Ellenbogen KA, Stambler BS, Orav EJ et al. Clinical characteristics of patients intolerant to VVIR pacing. Am. J. Cardiol. 86(1), 59–63 (2000).
  • Link MS, Hellkamp AS, Estes NA 3rd et al.; MOST Study Investigators. High incidence of pacemaker syndrome in patients with sinus node dysfunction treated with ventricular-based pacing in the Mode Selection Trial (MOST). J. Am. Coll. Cardiol. 43(11), 2066–2071 (2004).
  • Ellenbogen KA, Hellkamp AS, Wilkoff BL et al. Complications arising after implantation of DDD pacemakers: the MOST experience. Am. J. Cardiol. 92(6), 740–741 (2003).
  • Kirkfeldt RE, Johansen JB, Nohr EA, Moller M, Arnsbo P, Nielsen JC. Risk factors for lead complications in cardiac pacing: a population-based cohort study of 28,860 Danish patients. Heart Rhythm 8(10), 1622–1628 (2011).
  • Johansen JB, Jørgensen OD, Møller M, Arnsbo P, Mortensen PT, Nielsen JC. Infection after pacemaker implantation: infection rates and risk factors associated with infection in a population-based cohort study of 46299 consecutive patients. Eur. Heart J. 32(8), 991–998 (2011).
  • Poole JE, Gleva MJ, Mela T et al.; REPLACE Registry Investigators. Complication rates associated with pacemaker or implantable cardioverter-defibrillator generator replacements and upgrade procedures: results from the REPLACE registry. Circulation 122(16), 1553–1561 (2010).
  • O’Brien BJ, Blackhouse G, Goeree R et al. Cost–effectiveness of physiologic pacing: results of the Canadian Health Economic Assessment of Physiologic Pacing. Heart Rhythm 2(3), 270–275 (2005).
  • Deniz HB, Caro JJ, Ward A, Moller J, Malik F. Economic and health consequences of managing bradycardia with dual-chamber compared to single-chamber ventricular pacemakers in Italy. J. Cardiovasc. Med. (Hagerstown) 9(1), 43–50 (2008).
  • Caro J, Ward A, Moller J. Modelling the health benefits and economic implications of implanting dual-chamber vs. single-chamber ventricular pacemakers in the UK. Europace 8(6), 449–455 (2006).
  • Rinfret S, Cohen DJ, Lamas GA et al. Cost–effectiveness of dual-chamber pacing compared with ventricular pacing for sinus node dysfunction. Circulation 111(2), 165–172 (2005).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.